Endoscopy 2021; 53(07): E240-E241
DOI: 10.1055/a-1248-1991
E-Videos

Argon plasma coagulation performed as a treatment for restenosis after placement of two duodenal self-expandable metallic stents

Akihisa Ohno
1  Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
2  Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
,
Toyoma Kaku
1  Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
2  Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
,
Masayuki Hijioka
1  Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
2  Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
,
Naohiko Harada
1  Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
2  Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
,
Makoto Nakamuta
1  Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
2  Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
,
Ken Kawabe
1  Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
2  Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
› Author Affiliations
 

Malignant gastroduodenal outlet obstruction (MGOO) is occasionally seen in patients with advanced pancreatic cancer. The endoscopic placement of self-expandable metallic stents (SEMS) has proven to be an effective treatment for MGOO [1] [2]. However, the optimal treatment for MGOO that recurs after the placement of a duodenal SEMS remains unknown. Although a few reports have shown argon plasma coagulation (APC) to be effective for treating stenosis of metallic esophagogastric stents [3] [4] [5], the application of APC to malfunction of a duodenal SEMS has not yet been reported. Hence, we are the first to report the case of a patient who underwent APC for recurrent MGOO after placement of two duodenal SEMS.

An 82-year-old man with unresectable locally advanced pancreatic cancer underwent gemcitabine monotherapy after insertion of a duodenal SEMS for MGOO and endoscopic ultrasound-guided choledochoduodenostomy for obstructive jaundice. A year later, when MGOO recurred, an additional duodenal SEMS was inserted to treat it. Approximately 2 months after the second SEMS placement, the patient was admitted to our hospital with vomiting. Computed tomography revealed the SEMS to be obstructed by tumor ingrowth ([Fig. 1]). Insertion of a third SEMS seemed contraindicated on the grounds of cost and the patient’s overall poor prognosis. We therefore attempted to treat the duodenal SEMS malfunction using a 2.3-mm axial APC probe at the following settings: gas flow rate 1 L/min, current 40 – 50 W, effect 2 ([Video 1]). Although we were able under endoscopic guidance to cauterize the hyperplastic mucosa in the proximal part of the SEMS, the vomiting showed no improvement. The APC treatment was repeated 4 days later. In addition, under fluoroscopic guidance cauterization was performed along the guidewire in the distal part of the SEMS without any complications ([Fig. 2]). GOO-induced symptoms were not observed for 4 months after the APC treatment. After that, the patient died from pancreatic cancer progression.

Zoom Image
Fig. 1 Computed tomographic finding in an 82-year-old man with recurrent gastric outlet obstruction after placement of two SEMS. The first stent (WallFlex duodenal stent, 22 mm × 6 cm, uncovered type) was inserted into the third portion of the duodenum. The second duodenal stent (WallFlex duodenal stent, 22 mm × 9 cm, covered type) was inserted as a stent-in-a-stent for obstruction of the first SEMS due to tumor ingrowth.

Video 1 Argon plasma coagulation performed as a treatment for restenosis after placement of two duodenal self-expandable metallic stents.


Quality:
Zoom Image
Fig. 2 a, b Before the argon plasma coagulation treatment, imaging confirmed recurrent obstruction of the duodenal SEMS: a endoscopic findings, b fluoroscopic findings. c, d After the procedure, the duodenal lumen was visible: c endoscopic view, d fluoroscopic view.

APC may be an effective treatment for recurrent duodenal obstruction after SEMS placement.

Endoscopy_UCTN_Code_CPL_1AH_2AJ

Endoscopy E-Videos is a free access online section, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high
quality video and all contributions are
freely accessible online.

This section has its own submission
website at
https://mc.manuscriptcentral.com/e-videos


#

Competing interests

The authors declare that they have no conflict of interest.


Corresponding author

Ken Kawabe, MD, PhD
Department of Gastroenterology
National Hospital Organization Kyushu Medical Center
1-8-1 Jigyohama
Chuo-ku
Fukuoka 810-8563
Japan   
Fax: +81-92-847-8802   

Publication History

Publication Date:
23 September 2020 (online)

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany


Zoom Image
Fig. 1 Computed tomographic finding in an 82-year-old man with recurrent gastric outlet obstruction after placement of two SEMS. The first stent (WallFlex duodenal stent, 22 mm × 6 cm, uncovered type) was inserted into the third portion of the duodenum. The second duodenal stent (WallFlex duodenal stent, 22 mm × 9 cm, covered type) was inserted as a stent-in-a-stent for obstruction of the first SEMS due to tumor ingrowth.
Zoom Image
Fig. 2 a, b Before the argon plasma coagulation treatment, imaging confirmed recurrent obstruction of the duodenal SEMS: a endoscopic findings, b fluoroscopic findings. c, d After the procedure, the duodenal lumen was visible: c endoscopic view, d fluoroscopic view.